rxstat › Shortages › Insulin Injection Human Biosynthetic
Insulin Injection Human Biosynthetic shortage status
No current shortage
Reports by product
What's happening
There are no active shortage reports for Insulin Injection Human Biosynthetic. Health Canada has 2 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.
Insulin Injection Human Biosynthetic is classified under “INSULINS AND ANALOGUES” (ATC A10AB).
Recent changes
- No changes recorded yet.
Common questions
When will Insulin Injection Human Biosynthetic be back in stock in Canada?
Insulin Injection Human Biosynthetic has no active shortage; supply is normal per Health Canada reports.
Why is Insulin Injection Human Biosynthetic in shortage?
It isn't currently. Past reports and their reasons are listed above.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Related drugs (insulins and analogues)
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.